Exploring MMDA-2. To explore a different substance…

Names:
MMDA-2 · 2-Methoxy-4,5-methylenedioxyamphetamine
IUPAC names:
1-(6-Methoxy-2H-1,3-benzodioxol-5-yl)propan-2-amine
1-(6-Methoxy-1,3-benzodioxol-5-yl)propan-2-amine
ID: 133 · Formula: C11H15NO3 · Molecular weight: 209.242
InChI: InChI=1S/C11H15NO3/c1-7(12)3-8-4-10-11(15-6-14-10)5-9(8)13-2/h4-5,7H,3,6,12H2,1-2H3

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Shulgin, AT. Chemistry and structure-activity relationships of the psychotomimetics. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1970; pp 21–41. 8.6 MB.

Shulgin, AT; Sargent, T; Naranjo, C. Structure-activity relationships of one-ring psychotomimetics. Nature, 1 Jan 1969, 221, 537–541. 537 kB. http://dx.doi.org/10.1038/221537a0

Glennon, RA; Liebowitz, SM; Anderson, GM. Serotonin receptor affinities of psychoactive phenalkylamine analogues. J. Med. Chem., 1 Mar 1980, 23 (3), 294–299. 844 kB. http://dx.doi.org/10.1021/jm00177a017

Nichols, DE; Hoffman, AJ; Oberlender, RA; Riggs, RM. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: Drug discrimination studies in rats. J. Med. Chem., 1 Jan 1986, 29 (2), 302–304. 441 kB. http://dx.doi.org/10.1021/jm00152a022

Altun, A; Golcuk, K; Kumru, M; Jalbout, AF. Electron-conformation study for the structure-hallucinogenic activity relationships of phenylalkylamines. Bioorg. Med. Chem., 1 Dec 2003, 11 (24), 3861–3868. 577 kB. http://dx.doi.org/10.1016/S0968-0896(03)00437-1

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. http://dx.doi.org/10.1016/j.bmc.2003.10.027

McKenna, DJ; Guan, AM; Shulgin, AT. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav., 1 Jan 1991, 38 (3), 505–12. 783 kB. http://dx.doi.org/10.1016/0091-3057(91)90005-M

Glennon, RA; Rosecrans, JA; Young, R. Behavioral properties of psychoactive phenylisopropylamines in rats. Eur. J. Pharmacol., 17 Dec 1981, 76 (4), 353–360. 964 kB. http://dx.doi.org/10.1016/0014-2999(81)90106-0

N-Me-MMDA-2 · METHYL-MMDA-2
2C-2 · 2C-MMDA-2
4C-MMDA-2
2-Br-4,5-MDA
EMDA-2
6-Me-MDA · 6-Methyl-MDA
2-F-4,5-MDA · 6F-MDA
2-Cl-4,5-MDA
2-I-4,5-MDA
6N-MDA
6-MDOH
DMMDA-2
F-2
F-22
TMA-2
4T-MMDA-2
F
F-23
F-233
316
317
Asaricin
1112
Carpacin
FLEA
MDMEO
MMDA
MMDA-3a
MMDA-3b
MMDA-5
MMDA-4
2,5-DMA-βk · 2,5-Dimethoxycathinone
homo-MDOH
2,4-DMA-βk
N-iPr-DHPEA-βk
MHMC
HMMC
HOBDB
2-HO-N-Me-5-EPEA-βk
2-MDMOH
N-Me-2C-3a
2C-HM
6-MDMOH
β-Me-2C-2
5-MDMOH
N-Me-Lophophine
3,4-Dimethoxycathinone
2,4-Dimethoxycathinone
N-Me-MMDA-2 · METHYL-MMDA-2
2C-2 · 2C-MMDA-2
4C-MMDA-2
2-Br-4,5-MDA
EMDA-2
6-Me-MDA · 6-Methyl-MDA
2-F-4,5-MDA · 6F-MDA
2-Cl-4,5-MDA
2-I-4,5-MDA
6N-MDA
6-MDOH
DMMDA-2
F-2
F-22
TMA-2
4T-MMDA-2
F
F-23
F-233
316
317
Asaricin
1112
Carpacin
FLEA
MDMEO
MMDA
MMDA-3a
MMDA-3b
MMDA-5
MMDA-4
2,5-DMA-βk · 2,5-Dimethoxycathinone
homo-MDOH
2,4-DMA-βk
N-iPr-DHPEA-βk
MHMC
HMMC
HOBDB
2-HO-N-Me-5-EPEA-βk
2-MDMOH
N-Me-2C-3a
2C-HM
6-MDMOH
β-Me-2C-2
5-MDMOH
N-Me-Lophophine
3,4-Dimethoxycathinone
2,4-Dimethoxycathinone
20 November 2017 · Creative Commons BY-NC-SA ·